Antisense & RNAi Therapeutics Market Growth, Demand and Challenges of the Key Industry Players 2024-2032

1
Global Antisense RNAi Therapeutics Market
Research and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Antisense RNAi Therapeutics Market
  Global Industry Trends, Share, Size, Growth,
  Opportunity and Forecast 2024-2032," the global
  antisense RNAi therapeutics market size reached
  US 1.7 Billion in 2023.
• Antisense therapeutics involve the use of short,
  synthetic nucleotide sequences that are designed
  to bind complementary messenger RNA (mRNA)
  molecules and inhibit the translation of specific
  proteins. On the other hand, RNAi therapeutics
  utilize small interfering RNA (siRNA) molecules
  to silence the expression of disease-causing
  genes at the post-transcriptional level.
• As they offer enhanced treatment for genetic
  disorders, viral infections, and certain types of
  cancers, the demand for antisense and RNAi
  therapeutics is increasing across the globe.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/antisense-rnai-therapeu
  tics-market/requestsample

4
Report Description

• Global Antisense RNAi Therapeutics Market
  Trends
• At present, the rising demand for disease
  management to regulate gene expression is
  supporting the growth of the market. Besides
  this, the increasing adoption of antisense and
  RNAi therapies, as they offer highly specific and
  personalized approaches that cater to treatments
  to specific genetic profiles of individuals, is
  strengthening the growth of the market.
• In line with this, the growing demand for
  precision medicine among individuals is
  positively influencing the market. Apart from
  this, the increasing prevalence of
  neurodegenerative diseases, such as Alzheimer's
  and Parkinson's disease, across the globe is
  offering lucrative growth opportunities to
  industry investors. In addition, the rising
  demand for therapies that reduce disease
  progression is bolstering the growth of the
  market.
• Looking forward, the market value is projected to
  reach US 3.2 Billion by 2032, expanding at a
  CAGR of 7.25 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/antisense-rnai-therapeu
  tics-market

5
Report Segmentation

• Breakup by Technology
• RNA Interference
• siRNA
• miRNA
• Antisense RNA
•  
• Breakup by Route of Administration
• Intravenous Route
• Subcutaneous Route
• Intrathecal Route
• Pulmonary Delivery
• Intraperitoneal Injection
• Others
• Breakup by Application
• Oncology

6
Report Segmentation

• Cardiovascular Diseases (CVDs)
• Respiratory Disorders
• Renal Diseases
• Neurodegenerative Disorders
• Genetic Disorders
• Infectious Diseases
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Alnylam Pharmaceuticals Inc.,
• Arbutus Biopharma Corporation
• Arrowhead Pharmaceuticals Inc.
• Benitec Biopharma Ltd.
• Bio-Path Holdings Inc.
• Dicerna Pharmaceuticals Inc. (Novo Nordisk A/S)
• Ionis Pharmaceuticals Inc.
• OliX Pharmaceuticals Inc.
• Phio Pharmaceuticals Corp.
• Sarepta Therapeutics Inc.
• Silence Therapeutics
• Sirnaomics Inc.

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Antisense RNAi
  Therapeutics Market    5.1    Market Overview 
    5.2    Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Technology    6.1    RNA
  Interference        6.1.1 Market Trends       
  6.1.2 Key Segments           6.1.2.1 siRNA     
       6.1.2.2 miRNA        6.1.3 Market
  Forecast    6.2    Antisense RNA        6.2.1
  Market Trends        6.2.2 Market Forecast   
     

10
Table of Contents

• 7   Market Breakup by Route of Administration   
  7.1    Intravenous Route        7.1.1 Market
  Trends        7.1.2 Market Forecast    7.2  
   Subcutaneous Route        7.2.1 Market Trends 
        7.2.2 Market Forecast    7.3  
   Intrathecal Route        7.3.1 Market Trends 
        7.3.2 Market Forecast    7.4    Pulmonary
  Delivery        7.4.1 Market Trends       
  7.4.2 Market Forecast    7.5    Intraperitoneal
  Injection        7.5.1 Market Trends       
  7.5.2 Market Forecast    7.6    Others       
  7.6.1 Market Trends        7.6.2 Market
  Forecast8   Market Breakup by Application   
  8.1    Oncology        8.1.1 Market Trends     
    8.1.2 Market Forecast    8.2    Cardiovascular
  Diseases (CVDs)        8.2.1 Market Trends     
    8.2.2 Market Forecast
•     8.3    Respiratory Disorders        8.3.1
  Market Trends        8.3.2 Market Forecast
• For more information, visit https//www.imarcgrou
  p.com/antisense-rnai-therapeutics-market/toc

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com